Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...

Prior to joining Serina, Dr. Thomas served in progressive scientific leadership roles at Mersana Therapeutics, where during his 13 years he played a pivotal part in building out their discovery ...

The University of Delaware’s David Martin, Karl W. and Renate Böer Chair in the Department of Materials Science and Engineering, has been named to the National Academy of Inventors (NAI) 2025 Class of ...

Inhibiting prolactin receptor (PRLR) signaling with the ABS-201 anti-PRLR antibody promotes human hair follicle growth ex vivo Human ex vivo data validate ABS-201’s potential to reverse follicular ...

Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia December 11, 2025 10:00 AM ESTCompany ...

China's first national-level onshore shale oil demonstration zone has reached its annual crude output target of 1.7 million ...

Allied Market Research published a report, titled, "Immunostimulant Market by Product Type (Vaccines, Colony Stimulating ...

Igyxos Biotherapeutics is dedicated to developing innovative treatments for infertility in both men and women. Its lead asset, IGX12, is a first-in-class potentiating monoclonal antibody designed to ...

Golcadomide, a first-in-class, oral CELMoD (cereblon E3 ligase modulator), has shown compelling activity as a monotherapy and ...

Rondo Therapeutics, a clinical-stage biopharmaceutical company pioneering next-generation T-cell engaging bispecific antibodies for solid tumors, today announced that the first patient has been dosed ...

ORLANDO -- Adding four monthly infusions of novel ianalumab helped adults with primary immune thrombocytopenia (ITP) achieve durable disease control in the second-line setting while stopping daily ...

Flow Neuroscience AB received U.S. FDA 510(k) approval for its Flow at-home brain-stimulation device to treat major ...